108 related articles for article (PubMed ID: 1585391)
1. Radioimmunoassay of 5 beta-cholestane-3 alpha,7 alpha,12 alpha,25-tetrol 3-glucuronide in serum of patients with cerebrotendinous xanthomatosis.
Une M; Kataoka J; Nakata Y; Hoshita T
Steroids; 1992 Jan; 57(1):32-6. PubMed ID: 1585391
[TBL] [Abstract][Full Text] [Related]
2. Increased plasma bile alcohol glucuronides in patients with cerebrotendinous xanthomatosis: effect of chenodeoxycholic acid.
Batta AK; Salen G; Shefer S; Tint GS; Batta M
J Lipid Res; 1987 Aug; 28(8):1006-12. PubMed ID: 3668385
[TBL] [Abstract][Full Text] [Related]
3. Determination of the glucurono-conjugated position in bile alcohol glucuronides present in a patient with cerebrotendinous xanthomatosis.
Kuramoto T; Suemura Y; Kihira K; Hiraoka T; Hoshita T
Steroids; 1995 Oct; 60(10):709-12. PubMed ID: 8539780
[TBL] [Abstract][Full Text] [Related]
4. Biochemical studies of inherited diseases related to abnormal cholesterol metabolism. I. High-performance liquid chromatographic analysis of bile alcohol glucuronides in cerebrotendinous xanthomatosis.
Ohshima A; Kuramoto T; Hoshita T
Biol Pharm Bull; 1994 May; 17(5):721-3. PubMed ID: 7920441
[TBL] [Abstract][Full Text] [Related]
5. Cerebrotendinous xanthomatosis: a defect in cellular sterol biosynthetic control.
Barron JL; Maxwell JU; Rutherfoord GS
J Inherit Metab Dis; 1982; 5(2):91-3. PubMed ID: 6820431
[TBL] [Abstract][Full Text] [Related]
6. Occurrence of bile alcohol glucuronides in bile of patients with cerebrotendinous xanthomatosis.
Hoshita T; Yasuhara M; Une M; Kibe A; Itoga E; Kito S; Kuramoto T
J Lipid Res; 1980 Nov; 21(8):1015-21. PubMed ID: 7462799
[TBL] [Abstract][Full Text] [Related]
7. Determination of the glucurono-conjugated position in bile alcohol glucuronides excreted in urine of a patient with cerebrotendinous xanthomatosis by a nuclear magnetic resonance study.
Kuramoto T; Fukuda K; Ohshima A; Kihira K; Hoshita T
J Biochem; 1994 Apr; 115(4):655-8. PubMed ID: 8089079
[TBL] [Abstract][Full Text] [Related]
8. Bile alcohol profiles in bile, urine, and feces of a patient with cerebrotendinous xanthomatosis.
Shimazu K; Kuwabara M; Yoshii M; Kihira K; Takeuchi H; Nakano I; Ozawa S; Onuki M; Hatta Y; Hoshita T
J Biochem; 1986 Feb; 99(2):477-83. PubMed ID: 3700361
[TBL] [Abstract][Full Text] [Related]
9. Identifications of 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 23 beta-tetrol, 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 24 alpha-tetrol, and 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 24 beta-tetrol in cerebrotendinous xanthomatosis.
Yasuhara M; Kuramoto T; Hoshita T; Itoga E; Kito S
Steroids; 1978 Mar; 31(3):333-45. PubMed ID: 663972
[TBL] [Abstract][Full Text] [Related]
10. Stable isotope dilution assay for 5 beta-cholestane-3 alpha,7 alpha,12 alpha,25-tetrol and 5 beta-cholestane-3 alpha,7 alpha,12 alpha,23,25-pentol in human serum using [26,27-D6] labeled internal standards; a highly accurate approach to the serological diagnosis of cerebrotendinous xanthomatosis.
Kosaka D; Hiraoka T; Kohoda T; Kajiyama G; Yamauchi T; Kihira K; Kuramoto T; Hoshita T
Clin Chim Acta; 1991 May; 199(1):83-9. PubMed ID: 1934504
[No Abstract] [Full Text] [Related]
11. Detection of carriers of cerebrotendinous xanthomatosis.
Koopman BJ; Waterreus RJ; Van den Brekel HW; Wolthers BG
Clin Chim Acta; 1986 Jul; 158(2):179-85. PubMed ID: 3742821
[TBL] [Abstract][Full Text] [Related]
12. Bile alcohol glucuronides: regioselective O-glucuronidation of 5 beta-cholestane-3 alpha,7 alpha,12 alpha,25-tetrol and 24-nor-5 beta-cholestane-3 alpha,7 alpha,12 alpha,25-tetrol.
Dayal B; Salen G; Padia J; Shefer S; Tint GS; Sasso G; Williams TH
Carbohydr Res; 1993 Feb; 240():133-42. PubMed ID: 8458007
[TBL] [Abstract][Full Text] [Related]
13. Use of positive ion fast atom bombardment mass spectrometry for rapid identification of a bile alcohol glucuronide isolated from cerebrotendinous xanthomatosis patients.
Dayal B; Salen G; Tint GS; Shefer S; Benz SW
Steroids; 1990 Feb; 55(2):74-8. PubMed ID: 2183402
[TBL] [Abstract][Full Text] [Related]
14. Identification of (23S)-5 alpha-cholestane-3 alpha,7 alpha,12 alpha,23,25-pentol in urine of patients with cerebrotendinous xanthomatosis.
Kihira K; Fukuda K; Kuramoto T; Kuriyama M; Fujiyama J; Osame M; Hoshita T
Steroids; 1991 Sep; 56(9):464-8. PubMed ID: 1805458
[TBL] [Abstract][Full Text] [Related]
15. Absolute configuration at carbon 23 of 5 beta-cholestane-3 alpha,7 alpha,12 alpha,23,25-pentol excreted by patients with cerebrotendinous xanthomatosis.
Kihira K; Kubota A; Hoshita T
J Lipid Res; 1984 Aug; 25(8):871-5. PubMed ID: 6491531
[TBL] [Abstract][Full Text] [Related]
16. Cholic acid biosynthesis: the enzymatic defect in cerebrotendinous xanthomatosis.
Salen G; Shefer S; Cheng FW; Dayal B; Batta AK; Tint GS
J Clin Invest; 1979 Jan; 63(1):38-44. PubMed ID: 762246
[TBL] [Abstract][Full Text] [Related]
17. Aneurysmal coronary artery disease in cerebrotendinous xanthomatosis.
Potkin BN; Hoeg JM; Connor WE; Salen G; Quyyumi AA; Brush JE; Roberts WC; Brewer HB
Am J Cardiol; 1988 May; 61(13):1150-2. PubMed ID: 3364377
[No Abstract] [Full Text] [Related]
18. Cerebrotendinous xanthomatosis in three siblings from a Taiwanese family.
Chang WN; Kuriyama M; Lui CC; Jeng SF; Chen WJ; Chee EC
J Formos Med Assoc; 1992 Dec; 91(12):1190-4. PubMed ID: 1363642
[TBL] [Abstract][Full Text] [Related]
19. Identification of 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 25, 26-pentol in cerebrotendinous xanthomatosis.
Dayal B; Tint GS; Greeley DN; Williams TH; Salen G
Steroids; 1983 Oct; 42(4):441-8. PubMed ID: 6679948
[TBL] [Abstract][Full Text] [Related]
20. Isolation of 5 alpha-cholestane-3 beta, 7 alpha-diol from bile of patients with cerebrotendinous xanthomatosis. Inefficiency of this steroid as a precursor to cholestanol.
Björkhem I; Buchmann MS; Skrede S
Biochim Biophys Acta; 1983 Sep; 753(2):220-6. PubMed ID: 6412759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
